Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Operating Expenses (2016 - 2025)

MediWound has reported Operating Expenses over the past 13 years, most recently at $6.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 4.13% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $24.2 million, up 16.18%, while the annual FY2025 figure was $28.5 million, 29.44% up from the prior year.
  • Operating Expenses for Q4 2025 was $6.7 million at MediWound, up from $5.8 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $7.1 million in Q2 2025 and troughed at $3.2 million in Q1 2024.
  • A 5-year average of $5.2 million and a median of $5.1 million in 2021 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: crashed 34.03% in 2023 and later surged 51.83% in 2024.
  • Year by year, Operating Expenses stood at $5.1 million in 2021, then grew by 19.27% to $6.0 million in 2022, then fell by 23.56% to $4.6 million in 2023, then surged by 51.83% to $7.0 million in 2024, then dropped by 4.13% to $6.7 million in 2025.
  • Business Quant data shows Operating Expenses for MDWD at $6.7 million in Q4 2025, $5.8 million in Q3 2025, and $7.1 million in Q2 2025.